Literature DB >> 1479400

A further British case of growth hormone induced Creutzfeldt-Jakob disease.

C J Ellis1, H Katifi, R O Weller.   

Abstract

Transmission of Creutzfeldt-Jakob disease (CJD) from cadaveric growth hormone injections had previously been reported in 7 cases, including one from Britain. As a result, the treatment was abandoned in 1985 and superceded by safer recombinant DNA growth hormone injections. Recent reports now record the number of cases worldwide as 23, but with the incubation period being measured in years, new cases of CJD can still present. We give a detailed report of one of the recent cluster of British cases and aim to highlight the problem to clinicians who may encounter further patients with cadaveric growth hormone induced CJD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1479400      PMCID: PMC1015340          DOI: 10.1136/jnnp.55.12.1200

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

Review 1.  "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease.

Authors:  P Brown; M A Preece; R G Will
Journal:  Lancet       Date:  1992-07-04       Impact factor: 79.321

Review 2.  Iatrogenic transmission of Creutzfeldt-Jakob disease.

Authors:  R O Weller
Journal:  Psychol Med       Date:  1989-02       Impact factor: 7.723

3.  Creutzfeldt-Jakob disease in children treated with growth hormone.

Authors:  T B Billette de Villemeur; P Beauvais; M Gourmelen; J M Richardet
Journal:  Lancet       Date:  1991-04-06       Impact factor: 79.321

4.  The decline and fall of Creutzfeldt-Jakob disease associated with human growth hormone therapy.

Authors:  P Brown
Journal:  Neurology       Date:  1988-07       Impact factor: 9.910

5.  Improved method for the extraction and purification of human growth hormone.

Authors:  J B Mills; R B Ashworth; A E Wilhelmi; A S Hartree
Journal:  J Clin Endocrinol Metab       Date:  1969-11       Impact factor: 5.958

6.  Growth hormone 1985.

Authors:  R D Milner
Journal:  Br Med J (Clin Res Ed)       Date:  1985-12-07

7.  Preparation of growth hormone free from contamination with unconventional slow viruses.

Authors:  D M Taylor; A G Dickinson; H Fraser; P A Robertson; P R Salacinski; P J Lowry
Journal:  Lancet       Date:  1985-08-03       Impact factor: 79.321

8.  Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.

Authors:  J Collinge; M S Palmer; A J Dryden
Journal:  Lancet       Date:  1991-06-15       Impact factor: 79.321

9.  Large-scale preparation of highly purified pyrogen-free human growth hormone for clinical use.

Authors:  R L Jones; G Benker; P R Salacinski; T J Lloyd; P J Lowry
Journal:  J Endocrinol       Date:  1979-07       Impact factor: 4.286

10.  Creutzfeldt-Jakob disease: implications for growth hormone deficient children.

Authors:  M A Preece
Journal:  Neuropathol Appl Neurobiol       Date:  1986 Sep-Oct       Impact factor: 8.090

View more
  2 in total

Review 1.  Etiology and pathogenesis of prion diseases.

Authors:  S J DeArmond; S B Prusiner
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

2.  Who needs growth hormone?

Authors:  H F Stirling; C J Kelnar
Journal:  J R Soc Med       Date:  1994-09       Impact factor: 18.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.